NCT07584824 Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?
| NCT ID | NCT07584824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal Cornwall Hospitals Trust |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-09 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-01-09 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The 1939 Cancer Act in the UK (England \& Wales) prohibits advertising of cancer treatments to the public, by anyone but the NHS. The rise of the internet and social media presents new challenges to its enforcement and raises questions about unintended consequences for patients being treated for cancer. Through anonymous surveys, this study aims to understand how patients, healthcare professionals and industry professionals perceive technological changes and their implications for online and social media cancer care information, as well as highlight opportunities for safe and ethical modernisation.
Eligibility Criteria
Inclusion Criteria: Patients/Relatives: * UK residents (England and Wales ONLY). * Have been treated for a cancer within the last three years. * Aged 18 or over. * Can complete the survey themselves or have it completed on their behalf by a friend or family member (with the patient's permission). Healthcare Professionals: * UK-based professionals in the healthcare industry. * Working with patients diagnosed with cancer. * Consulting with patients at least once a month or more frequently. * Aged 18 or over. Exclusion Criteria: No explicit exclusion criteria are defined within provided materials, therefore any individual not meeting the inclusion criteria will be excluded.
Frequently Asked Questions
Who can join the NCT07584824 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07584824 currently recruiting?
Yes, NCT07584824 is actively recruiting participants. Visit ClinicalTrials.gov or contact Royal Cornwall Hospitals Trust to inquire about joining.
Where is the NCT07584824 trial being conducted?
This trial is being conducted at Truro, United Kingdom.
Who is sponsoring the NCT07584824 clinical trial?
NCT07584824 is sponsored by Royal Cornwall Hospitals Trust. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.